Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 7,700 shares at $32.05 ($247K) on 2021-11-17, disclosed to the SEC on 2021-11-19.
Open-market sale of $247k ADPT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.05 | 3,700 | $119K | 48.1% |
| 2 | $32.05 | 3,700 | $119K | 48.1% |
| 3 | $31.36 | 300 | $9K | 3.8% |
| Total | $32.02 avg | 7,700 | $247K | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |